Valion Bio, Inc. (VBIO) Net margin 2021–2024
Valion Bio, Inc. (VBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-725.0%FY2024 · since FY2021: -675.7% → -725.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -725.0% | -24.0 pp |
| FY2023 | -701.0% | -152.3 pp |
| FY2022 | -548.7% | +127.0 pp |
| FY2021 | -675.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice